HT
SUPN icon

Headlands Technologies’s Supernus Pharmaceuticals SUPN Stock Holding History

Headlands Technologies’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
+6,535
New +$314K 0.03% 532
2026
Q1 		– Sell
-22,473
Closed -$1.12M – 961
2025
Q4 		$1.12M Buy
22,473
+17,861
+387% +$868K 0.09% 251
2025
Q3 		$220K Buy
+4,612
New +$186K 0.02% 524
2025
Q1 		– Sell
-1,515
Closed -$54.8K – 1511
2024
Q4 		$54.8K Buy
1,515
+1,015
+203% +$35.7K 0.01% 796
2024
Q3 		$15.6K Sell
500
-6,007
-92% -$187K ﹤0.01% 976
2024
Q2 		$174K Buy
+6,507
New +$189K 0.02% 509

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Headlands Technologies's SUPN Position: Q2 2026 in Review

Headlands Technologies opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 6,535 shares worth $304K. The stake represents 0.03% of the portfolio and ranks #532 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in SUPN as recently as Q4 2025.

Headlands Technologies first reported a position in SUPN in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.12M in Q4 2025. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Headlands Technologies held 6,535 shares of Supernus Pharmaceuticals worth $304K as of Q2 2026.
  • Supernus Pharmaceuticals was a new Headlands Technologies position in Q2 2026.
  • Supernus Pharmaceuticals made up 0.03% of Headlands Technologies's portfolio in Q2 2026, its #532 holding.
  • Headlands Technologies first reported a position in Supernus Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • Headlands Technologies's Supernus Pharmaceuticals position peaked at $1.12M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.